<DOC>
	<DOCNO>NCT02933476</DOCNO>
	<brief_summary>The purpose study examine possibility new , non-invasive , non-drug treatment Parkinson 's disease . The treatment involve gentle vibratory stimulation deliver fingertip ( call 'vibrotactile stimulation ' ) . Along treatment , participant also undergo kinematic testing .</brief_summary>
	<brief_title>Vibrotactile Stimulation Parkinson 's Disease</brief_title>
	<detailed_description>Patient phone screen and/or physical neurological examination determine appropriate participate study . This test include Unified Parkinson 's Disease Rating Scale , Part III ( UPDRS III ) . Research assistant explain study obtain informed consent . There three consecutive day test , well 2 follow visit 1 4 week . Visits include follow : Patients sensor put hand , foot , chest . These sensor measure movement perform kinematic task forward walk , wrist movement , UPDRS III . Patients also give vibrotactile stimulation total 4 hour throughout day . During time , patient provide books/movies entertainment , may move around freely . Patients also ask complete several questionnaire throughout visit Parkinson 's symptom .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>1 . Age least 18 year age . 2 . Speaks understand English . 3 . A diagnosis idiopathic Parkinson 's disease , Hoehn Yahr Stage II III 4 . Able willing come study visit ( 3 consecutive day , well 2 follow visit , 1 4 week ) 5 . Able willing stop therapy daytime day come clinic study . 6 . Have improvement motor sign ON versus OFF dopaminergic medication . 7 . If medication , patient stable dos Sinemet and/or Stalevo ( Carbidopa/Levodopa Parkinson 's medication ) part medicinal regimen ( Patient need medication include study ) . 1 . Subjects , pregnant , capable become pregnant , breast feeding . 2 . Subjects advance Parkinson 's disease , Hoehn Yahr stage IV medication ( nonambulatory ) . 3 . Have significant cognitive impairment and/or dementia , determine neurologist Stanford Movement Disorders Clinic . 4 . Have implant electronic device cardiac pacemaker/defibrillator medication pump . 5 . Subjects inability comply study followup visit . 6 . Subjects unable understand sign inform consent . 7 . Have MRI show focal brain lesion could indicate nonidiopathic movement disorder . 8 . Have active infection . 9 . Require diathermy , electroconvulsive therapy ( ECT ) , transcranial magnetic stimulation ( TMS ) treat chronic condition .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>